Navigation Links
GTX Corp Expands Partner Alliance in Preparation for GPS Shoe Launch
Date:10/19/2011

LOS ANGELES, Oct.19, 2011 /PRNewswire/ -- GTX Corp (OTCBB: GTXO), a leader in customizable,  2-way GPS Personal Location Services (PLS) solutions, today announced entering into a Fulfillment and Customer Service Agreement with Aetrex Worldwide, Inc. and Omnilink Systems, who built and maintains a market leading tracking solution for individuals with Alzheimer's. Under the Agreement, Omnilink will provide an e-commerce and customer service platform for the Aetrex GPS Shoe scheduled to go on sale this month in the US, enhancing the sales, marketing and customer support for the GPS Shoe and user community.  MedicAlert Foundation, known for their live 24/7 emergency medical information and identification services, has joined the alliance and will provide 24/7 location based emergency services for Aetrex GPS Shoe customers.

The Partner Alliance was created to provide a world class, senior-friendly, 24/7 customer support platform for consumers and caregivers  to assist in selecting monthly plans, GPS Shoe features, best use tips and general overall customer service. The Agreement will allow GTX Corp and Aetrex to concentrate on their core competencies while the Partner Alliance handles support, e-commerce and customer care for this new potential life saving technology.

"As the GPS Shoe transitions from vision to reality and we approach the launch we are excited and honored to align ourselves with these exceptional companies," stated Patrick Bertagna, GTX Corp Chairman and CEO.

"Omnilink has had the privilege of building unique solutions for helping ensure the safety and security of individual's with Alzheimer's," says Kelly Gay, Omnilink's President and CEO. "We are very excited to now have the GPS shoe available as one of the first human-wearable, location-monitoring device options for this market."

The

SOURCE GTX Corp
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
2. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
3. Cellectar Expands Clinical Management Team
4. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
5. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
6. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
7. PAREXEL Expands Global Clinical Pharmacology Capabilities
8. BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer
9. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
10. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
11. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015 An aggressive ... helped cut the rate of infection with a dangerous ... percent. Clostridium difficile, or C.diff, is a ... life-threatening inflammation of the colon. A recent article in ... Clostridium difficile Infection in the United States ...
(Date:2/27/2015)... Feb. 27, 2015 /CNW/ - Covalon Technologies Ltd. (the "Company" ... today announced financial results for its first quarter ended ... months ended December 31, 2014, revenue was $1,336,685. Operating ... $229,820 or $0.02 per share.  Covalon,s ... am very pleased with the significant progress we have ...
(Date:2/27/2015)... 2015  Bionik Laboratories Corp. (OTC:DWTPD), a ... it acquired Bionik Laboratories, Inc., a Toronto ... to qualified accredited investors of units consisting of its ... approximately $6.2 million. Shares of the Company,s common stock ... under the symbol "DWTPD" until FINRA,s approval of the ...
Breaking Medicine Technology:Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 2Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 3Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3
... West Pharmaceutical Services, Inc. (NYSE: WST ) today ...  Summary comparative results were as follows: ($ millions, except per-share ... $ 281.8Gross Profit , 84.6 , 83.2Reported Operating Profit , ... 30.5 , 30.9Reported Diluted EPS , $ 0.57 , $ ...
... SEATTLE, July 28, 2011 Cell Therapeutics, Inc. ("CTI" or ... its efforts to develop its late stage oncology pipeline to ... ended June 30, 2011. "In the second quarter, ... the FDA,s Office of New Drugs ("OND") in allowing us ...
Cached Medicine Technology:West Announces Second Quarter 2011 Results 2West Announces Second Quarter 2011 Results 3West Announces Second Quarter 2011 Results 4West Announces Second Quarter 2011 Results 5West Announces Second Quarter 2011 Results 6West Announces Second Quarter 2011 Results 7West Announces Second Quarter 2011 Results 8West Announces Second Quarter 2011 Results 9West Announces Second Quarter 2011 Results 10West Announces Second Quarter 2011 Results 11West Announces Second Quarter 2011 Results 12West Announces Second Quarter 2011 Results 13West Announces Second Quarter 2011 Results 14West Announces Second Quarter 2011 Results 15West Announces Second Quarter 2011 Results 16Cell Therapeutics, Inc. (CTI) Reports Reduction in Operating Expenses and Net Losses for Second Quarter and First Half 2011 Compared to 2010, and Advances In Bringing Pixantrone to Market 2Cell Therapeutics, Inc. (CTI) Reports Reduction in Operating Expenses and Net Losses for Second Quarter and First Half 2011 Compared to 2010, and Advances In Bringing Pixantrone to Market 3Cell Therapeutics, Inc. (CTI) Reports Reduction in Operating Expenses and Net Losses for Second Quarter and First Half 2011 Compared to 2010, and Advances In Bringing Pixantrone to Market 4Cell Therapeutics, Inc. (CTI) Reports Reduction in Operating Expenses and Net Losses for Second Quarter and First Half 2011 Compared to 2010, and Advances In Bringing Pixantrone to Market 5Cell Therapeutics, Inc. (CTI) Reports Reduction in Operating Expenses and Net Losses for Second Quarter and First Half 2011 Compared to 2010, and Advances In Bringing Pixantrone to Market 6
(Date:2/28/2015)... 28, 2015 A case management conference ... that have been filed by law firms including Bernstein ... in March, the Firm notes. , According to ... in the federal litigation will meet on March 13, ... prescription therapy treatments designed to raise levels of the ...
(Date:2/28/2015)... Ohio (PRWEB) February 28, 2015 ... Motivational? Supportive? Strategic? , There are all kinds ... strengths. To raise awareness of the advantages and ... firm PeopleKeys is launching a new product this ... clients better understand the connection between personality type, ...
(Date:2/28/2015)... The noted Friedman Dental Group of South ... relaunched their website. The new version of the site ... new section about their team members. Potential and current ... of each Friedman Dental Group team member including new ... to provide our patients with the opportunity to get ...
(Date:2/28/2015)... 28, 2015 Developers of FCPX ... new overlay plugin for Final Cut Pro X entitled FCPX ... Overlay Chromatic gives users total control over 6k lens dirt ... of Pixel Film Studios. “FCPX Overlay Chromatic was professionally designed ... use interface.” , FCPX Overlay Chromatic Grunge 6K is a ...
(Date:2/28/2015)... “ Powermod ” was featured on NewsWatch as ... at the latest and coolest technology products and services available ... a technology expert, conducted the review and shared with viewers ... Getting stuck with a low battery and no way to ... face on a daily basis. Even when a person does ...
Breaking Medicine News(10 mins):Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4Health News:PeopleKeys Launches The Leadership Report 2Health News:PeopleKeys Launches The Leadership Report 3Health News:Friedman Dental Group Announces Their Updated Website 2Health News:Pixel Film Studios released a new overlay plugin entitled FCPX Overlay Chromatic Grunge 6K exclusively for Final Cut Pro X users 2Health News:Solutions to Keep Phones Charged were Featured on NewsWatch Television on January 29, 2015 2
... A major research company with expertise in managing clinical ... Medical Campus to more efficiently bring the latest stem ... formally known as the Colorado Prevention Center, officially moved ... from the campus on Friday., It is the ...
... poor judges of their patients, health beliefs, according to ... A&M University and Paul Haidet from The Pennsylvania State ... is better the more patients are involved by asking ... for care. Their analysis 1 of how ...
... undergo cardiopulmonary bypass (CPB) during surgery for less ... suffer any impairments in neurocognitive abilities, such as ... Researchers from The Children,s Hospital of Philadelphia, in ... Pediatrics , reported on neuropsychological effects after surgery ...
... , , , , ... AUDIO: Scientists at Washington University School of Medicine in St. ... Click here for more information. , , ... , , , , , , ...
... Gardner HealthDay Reporter , THURSDAY, July 22 (HealthDay ... favorite pastimes -- sitting around -- the shorter their average ... remained even after researchers factored out obesity or the level ... a study of more than 120,000 American adults. It,s ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, July ... face a greater risk of having a stillborn child if ... treatments, a new study finds. Although neither boys nor ... that might affect their offspring, radiation damage to the uterus ...
Cached Medicine News:Health News:University of Colorado joins with major research firm to partner on stem cell research 2Health News:Doctors don't 'get' their patients 2Health News:Heart bypass for uncomplicated heart surgery does not reduce neurocognitive function in children 2Health News:Inhibiting fatty acids in immune cells decreases atherosclerosis risk 2Health News:Inhibiting fatty acids in immune cells decreases atherosclerosis risk 3Health News:Inhibiting fatty acids in immune cells decreases atherosclerosis risk 4Health News:The Longer You Sit, the Shorter Your Life Span: Study 2Health News:Radiation for Childhood Cancer Can Boost Risk of Stillbirth Later 2Health News:Radiation for Childhood Cancer Can Boost Risk of Stillbirth Later 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: